Cinacalcet Tablet, Film Coated
Product Images NDC 72162-1844

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Cinacalcet (NDC 72162-1844). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cinacalcet-fig3 (Cinacalcet Fig3)

Cinacalcet-fig3 (Cinacalcet Fig3)
A line graph showing calcium level measurements (mg/dL) over weeks in patients with parathyroid carcinoma. The x-axis represents time in weeks from baseline through titration to maintenance periods, and the y-axis shows calcium concentrations ranging approximately from 8 to 16 mg/dL. Data points include error bars indicating variability, with sample sizes noted below the x-axis.*
FDA Label Image

Cinacalcet-fig4.jpg (Cinacalcet Fig4)

Cinacalcet-fig4.jpg (Cinacalcet Fig4)
This is a line graph depicting serum calcium levels (mg/dL) over weeks in patients receiving Cinacalcet. The x-axis shows weeks from baseline through titration and maintenance phases, while the y-axis indicates calcium concentration. Data points with error bars illustrate mean calcium values and variability across the study period.*
FDA Label Image

Cinacalcet-figure-1.jpg (Cinacalcet Figure 1)

Cinacalcet-figure-1.jpg (Cinacalcet Figure 1)
A line chart titled 'Mean (SE) iPTH Values (Pooled Phase 3 Studies)' comparing iPTH levels (pg/mL) over 26 weeks between placebo and Cinacalcet groups. The chart shows two lines with error bars, with Cinacalcet group values decreasing steadily while placebo levels remain relatively stable.*
FDA Label Image

Cinacalcet-figure-2 (Cinacalcet Figure 2)

Cinacalcet-figure-2 (Cinacalcet Figure 2)
Line graph titled 'Mean (SE) Ca x P Values (Pooled Phase 3 Studies)' showing the change in calcium-phosphorus (Ca x P) product levels over 26 weeks. The X-axis represents weeks, and the Y-axis shows Ca x P (mg/dL)². Two lines compare placebo and Cinacalcet groups, with mean values and error bars displayed for each week.*
FDA Label Image

Cinacalcet-str (Cinacalcet Str)

Cinacalcet-str (Cinacalcet Str)
Chemical structure of cinacalcet hydrochloride shown with its molecular arrangement including aromatic rings and trifluoromethyl group.*
FDA Label Image

Label (Lbl721621844)

Label (Lbl721621844)
This drug label is for Cinacalcet Tablets 60 mg, film-coated, oral tablets. The label indicates the product is relabeled by Bryant Ranch Prepack, located in Burbank, CA, and manufactured by Alkem Laboratories Ltd. The package contains 30 tablets and includes storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.